Expiring federal contract · order under a contract vehicle
75N90024F00080 — Ino Therapeutics LLC
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N90024F00080
- Incumbent
- Ino Therapeutics LLC
- Incumbent UEI
- XXQHL619FUN6
- Current end date
- February 28, 2027
- Potential total value
- $115,000
- Obligated
- $115,000
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- 6515 — MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Set-aside
- Not stated
- Start date
- July 1, 2024
- Place of performance
- NJ
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
THE CRITICAL CARE MEDICINE DEPARTMENT (CCMD) IS IN NEED OF NITRIC OXIDE GAS TO TREAT CRITICALLY ILL PATIENT.
Likely rebid window (estimate)
- Sources Sought / RFI: about Feb 2026 – Aug 2026 (6–12 months before the end date)
- RFP: about Oct 2026 – Dec 2026 (2–4 months before the end date)
Now inside the estimated RFP window.
This is an order under contract vehicle V797D60737. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325412)
- 75H71226F80004 — Mckesson Corporation · ends November 25, 2026 · $114K
- 75H71224P00137 — Four Points Technology, L.L.C. · ends November 30, 2026 · $240K
- 75H71226F80005 — Mckesson Corporation · ends December 21, 2026 · $1.6M
- 75H71026P00562 — Mckesson Corporation · ends December 31, 2026 · $131K
- 75N92026P00029 — Medunik USA INC · ends December 31, 2026 · $210K
- 75N93024P01131 — United Biopharma, INC. · ends December 31, 2026 · $400K
- 75A50120C00092 — Phlow Corp. · ends January 13, 2027 · $697M
- 75D30123C17978 — Mckesson Specialty Distribution LLC · ends January 31, 2027 · $204M
- 75N95019F00088 — Mriglobal · ends January 31, 2027 · $2.4M
- 75H71126F80051 — Sanofi Vaccines US INC. · ends March 14, 2027 · $2.0M